OSCR
Oscar Health, Inc.
NYSE · Healthcare · Medical - Healthcare Plans · US
$32.30
+0.17%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 15.3B | 11.7B | 9.2B | 5.9B | 4.1B |
| Cost of Revenue | 8.4B | 10.0B | 7.3B | 4.6B | — |
| Gross Profit | 6.9B | 1.7B | 1.8B | 1.2B | 4.1B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 1.2B | 2.0B | — | — | 1.4B |
| General & Admin Expense | 511.0M | 2.0B | — | — | 1.4B |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 5.0B | 28.9M | 1.8B | 1.5B | 3.3B |
| Total Operating Expenses | 6.3B | 2.1B | 1.8B | 1.5B | 4.7B |
| Cost and Expenses | 14.7B | 12.1B | 9.1B | 6.1B | 4.7B |
| Operating Income (EBIT) | 624.1M | (396.4M) | 57.3M | (235.6M) | (610.1M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 15.9M | 17.6M | 23.7M | 24.6M | 22.6M |
| Net Interest Income | (15.9M) | (17.6M) | (23.7M) | (24.6M) | (22.6M) |
| Other Non-Op Income/Expense | (34.3M) | (40.9M) | (23.8M) | (31.7M) | — |
| Non-Operating Income (excl Interest) | 18.4M | 23.3M | 105.0K | 7.1M | (22.6M) |
| EBT (Pre-Tax Income) | 589.8M | (437.3M) | 33.4M | (267.3M) | (610.1M) |
| Income Tax Expense | 38.9M | 5.6M | 7.3M | 3.3M | (523.0K) |
| Bottom Line | |||||
| Net Income | 550.7M | (443.2M) | 25.4M | (270.7M) | (606.3M) |
| Earnings from Cont. Ops | 550.9M | (442.9M) | 26.1M | (270.6M) | (609.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 550.7M | (443.2M) | 25.4M | (270.7M) | (606.3M) |
| Per Share | |||||
| Basic EPS | $1.71 | ($1.69) | $0.11 | ($1.22) | ($2.85) |
| Diluted EPS | $1.40 | ($1.69) | $0.10 | ($1.22) | ($2.85) |
| Revenue Per Share | $50.69 | $44.60 | $38.18 | $26.45 | $19.42 |
| Shares | |||||
| Basic Shares Outstanding | 302.2M | 262.4M | 240.4M | 221.7M | 212.5M |
| Diluted Shares Outstanding | 333.4M | 262.4M | 265.9M | 221.7M | 212.5M |
| Profitability Metrics | |||||
| EBITDA | 633.7M | (391.1M) | 89.3M | (212.0M) | (572.2M) |
| D&A | 28.3M | 28.9M | 32.1M | 30.7M | 15.3M |
| EBIT | 605.7M | (419.7M) | 57.2M | (242.7M) | (587.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026